SARS-COV-2 Omicron variants conformationally escape a rare quaternary antibody binding mode
-
Published:2023-12-11
Issue:1
Volume:6
Page:
-
ISSN:2399-3642
-
Container-title:Communications Biology
-
language:en
-
Short-container-title:Commun Biol
Author:
Goike Jule, Hsieh Ching-LinORCID, Horton Andrew P.ORCID, Gardner Elizabeth C., Zhou Ling, Bartzoka Foteini, Wang Nianshuang, Javanmardi Kamyab, Herbert Andrew, Abbassi Shawn, Xie XupingORCID, Xia HongjieORCID, Shi Pei-YongORCID, Renberg RebeccaORCID, Segall-Shapiro Thomas H., Terrace Cynthia I., Wu Wesley, Shroff Raghav, Byrom Michelle, Ellington Andrew D.ORCID, Marcotte Edward M.ORCID, Musser James M., Kuchipudi Suresh V.ORCID, Kapur Vivek, Georgiou GeorgeORCID, Weaver Scott C.ORCID, Dye John M., Boutz Daniel R.ORCID, McLellan Jason S.ORCID, Gollihar Jimmy D.ORCID
Abstract
AbstractThe ongoing evolution of SARS-CoV-2 into more easily transmissible and infectious variants has provided unprecedented insight into mutations enabling immune escape. Understanding how these mutations affect the dynamics of antibody-antigen interactions is crucial to the development of broadly protective antibodies and vaccines. Here we report the characterization of a potent neutralizing antibody (N3-1) identified from a COVID-19 patient during the first disease wave. Cryogenic electron microscopy revealed a quaternary binding mode that enables direct interactions with all three receptor-binding domains of the spike protein trimer, resulting in extraordinary avidity and potent neutralization of all major variants of concern until the emergence of Omicron. Structure-based rational design of N3-1 mutants improved binding to all Omicron variants but only partially restored neutralization of the conformationally distinct Omicron BA.1. This study provides new insights into immune evasion through changes in spike protein dynamics and highlights considerations for future conformationally biased multivalent vaccine designs.
Publisher
Springer Science and Business Media LLC
Subject
General Agricultural and Biological Sciences,General Biochemistry, Genetics and Molecular Biology,Medicine (miscellaneous)
Reference43 articles.
1. Zhou, P. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579, 270–273 (2020). 2. Wu, F. et al. A new coronavirus associated with human respiratory disease in China. Nature 579, 265–269 (2020). 3. Campos, D. M., de, O., Fulco, U. L., de Oliveira, C. B. S. & Oliveira, J. I. N. SARS-CoV-2 virus infection: Targets and antiviral pharmacological strategies. J. Evid. -Based Med. 13, 255–260 (2020). 4. Volz, E. et al. Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England. Nature 1–6 https://doi.org/10.1038/s41586-021-03470-x (2021) 5. Tegally, H. et al. Detection of a SARS-CoV-2 variant of concern in South Africa. Nature 592, 438–443 (2021).
|
|